Press releases

Next-generation coronary stent employs innovative alloy designed to improve acute performance.

TELIGEN family of ICDs, designed to treat sudden cardiac death, are the smallest and thinnest high-energy devices available in China.

ION™ and TAXUS® Liberte® Paclitaxel-Eluting Stent Systems now approved for treating patients with acute myocardial infarction in the U.S.

Moody's Investors Service has upgraded the Company's corporate credit rating to an investment grade rating, Baa3, with a stable outlook.

TruePath™ CTO Device designed to facilitate crossing of chronic total occlusions.

Studies published in peer-reviewed medical journals

New device offers excellent flexibility and large size for acquiring tissue samples.

“We continue to make progress with new product introductions, cost-saving initiatives and a strengthened presence in emerging markets," said CEO Hank Kucheman.

Platinum chromium coronary stent with enhanced delivery system now available in Europe and other international countries.

NICE report supports safety and effectiveness of Alair® System